Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
16. November 2021 09:58 ET
|
Protagenic Therapeutics, Inc.
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders,...
Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET
30. August 2021 09:15 ET
|
Protagenic Therapeutics, Inc.
Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction to be discussed NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Protagenic...